Brinker Capital Investments’s AngioDynamics ANGO Stock Holding History
Bought
Maintained
Sold
Other funds holding ANGO
SFM
AC
RA
BH
WCM
Brinker Capital Investments's ANGO Position: Q2 2026 in Review
Brinker Capital Investments increased its AngioDynamics (ANGO) stake by 43% in Q2 2026, buying an estimated $636K and bringing the position to 185,844 shares worth $2.42M. The position accounts for 0.02% of the portfolio, ranked #690.
Brinker Capital Investments first reported a position in ANGO in Q3 2020 and has held it in 23 quarters since. 161 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.
- Brinker Capital Investments held 185,844 shares of AngioDynamics worth $2.42M as of Q2 2026.
- Brinker Capital Investments bought 55,883 AngioDynamics shares in Q2 2026, an estimated $636K.
- AngioDynamics made up 0.02% of Brinker Capital Investments's portfolio in Q2 2026, its #690 holding.
- Brinker Capital Investments first reported a position in AngioDynamics in Q3 2020 and has held it in 23 quarters since.
- 161 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.
Based on Brinker Capital Investments's 13F filing for Q2 2026, filed 14 Aug 2026.